Antibody-Mediated Rejection research hub
3 indexed studies · 0 currently recruiting
- active not recruitingPHASE2
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
This study looks at a new drug, ALXN2030, to help people who have had a kidney transplant and are now experiencing a problem called antibody-mediated rejection (AMR). We want to see if the drug can help the kidney recover.
United States · Brazil · Canada - active not recruiting
VIRTUUS Children's Study
This study looks for new, gentle ways to check the health of kidney transplants in children. It aims to find early signs of problems like rejection or infection without needing a biopsy, helping transplanted kidneys last longer.
United States · Canada - active not recruitingPHASE3
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)
This study looks at a new drug, felzartamab, for adults with kidney transplants experiencing antibody-mediated rejection (AMR). AMR is when the body's immune system attacks the new kidney. Researchers want to see if felzartamab can help the kidney recover and reduce damage.
United States · Argentina · Australia